x
Growing evidence suggests that protecting yourself against shingles might also guard your heart. Recent analyses indicate that people who receive the shingles vaccine experience a lower risk of cardiovascular events, including heart attack, heart failure, and stroke. While the findings are promising, experts caution that more research is needed to confirm causality. Still, the potential heart-health benefit adds another compelling reason to consider vaccination, especially for adults 50 and older who are already advised to get vaccinated to prevent shingles and its complications.
Large observational studies have observed a link between shingles vaccination and reduced rates of cardiovascular problems. After accounting for factors like age, sex, socioeconomic status, and existing health conditions, researchers consistently report a notable decrease in incidents such as myocardial infarction, stroke, and heart failure among those who were vaccinated compared with those who were not. The association remains even when researchers use statistical methods designed to minimize bias and account for differences between groups. However, because these studies are not randomized, they can’t prove that the vaccine protects the heart directly—only that there’s a meaningful association that deserves further investigation.
The connection makes biological sense for a few reasons. Herpes zoster (shingles) is caused by reactivation of the varicella-zoster virus. When shingles flares, it triggers systemic inflammation and vascular stress. Inflammation is a known driver of atherosclerosis and can destabilize plaques, potentially leading to heart attacks or strokes in the weeks and months after a shingles episode. By preventing shingles, the vaccine reduces these inflammatory bursts and the corresponding strain on the cardiovascular system. In addition, fewer shingles-related complications mean fewer hospitalizations and physiological stress, both of which can tip the balance for people with existing heart risk factors.
For individuals, these findings reinforce the value of preventive health measures. Vaccination can be a simple, effective step in a broader strategy to protect long-term heart health, especially when paired with a heart-healthy lifestyle—regular exercise, balanced nutrition, smoking cessation, and routine screening for blood pressure and cholesterol. For employers and organizations, a healthier workforce translates into fewer sick days, lower healthcare costs, and enhanced productivity. Integrating shingles vaccination into workplace wellness programs can be a practical, proactive move—supporting staff health while reinforcing a culture that prioritizes preventive care.
As with all observational research, these studies can be influenced by confounding factors. People who get vaccinated may also engage in other health-promoting behaviors that reduce cardiovascular risk, which can skew results. While adjustments help, they cannot fully rule out bias. Randomized controlled trials would be needed to establish a clear causal link between shingles vaccination and reduced heart disease risk. In the meantime, safety profiles for shingles vaccines are favorable, and the vaccines are highly effective at preventing shingles and its painful complications.
Thomas Prendergast (clone)
By his direction
